Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2018

Conditions
Metastatic Prostate Cancer
Interventions
DRUG

11C-choline Injection

"1. Choline C11 Injection for PET/CT Imaging Protocol:~ * 15 - millicuries (mCi) 11C-choline IV Injection~ * PET images skull base to mid thigh with 3 min per bed position~ * Use of IV contrast based on American College of Radiology (ACR) IV contrast guidelines for a renal function screening protocol~ * Fusion of PET and CT images~2. Choline C11 Injection for PET/MRI Whole Body Imaging Protocol:~ * No IV contrast~ * High resolution axial T2 prostate bed, axial Diffusion Weighted Image (DWI) pelvis, coronal T2 skull base to mid thighs~ * Fusion of coronal and PET images"

Trial Locations (1)

62526

Decatur Memorial Hospital, Decatur

All Listed Sponsors
lead

Global Isotopes, LLC d/b/a Zevacor Molecular

INDUSTRY

NCT02260817 - Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter